您好, 歡迎來(lái)到環(huán)保在線! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:上海谷博實(shí)業(yè)有限公司>>科研試劑>>美國(guó)cayman>> Cayman-10235-508-iso Prostaglandin A2
參 考 價(jià) | 面議 |
產(chǎn)品型號(hào)Cayman-10235-50
品 牌
廠商性質(zhì)代理商
所 在 地上海市
更新時(shí)間:2018-04-29 16:01:49瀏覽次數(shù):662次
聯(lián)系我時(shí),請(qǐng)告知來(lái)自 環(huán)保在線9(Z),11(E)-Conjugated Linoleic Acid
1-NBD-decanoyl-2-decanoyl-sn-Glycer
8-iso Prostaglandin A2 | Cayman-10235-50 |
PCSK9 Polyclonal Antibody | Cayman-10240-1 |
β-Amyloid (1-8) Peptide | Cayman-10241-1 |
11β-Hydroxysteroid Dehydrogenase (Type 2) Blocking Peptide | Cayman-10242-1 |
LSD1 (human recombinant) | Cayman-10245-100 |
LSD1 (human recombinant) | Cayman-10245-25 |
LSD1 (human recombinant) | Cayman-10245-50 |
Programmed Cell Death Protein 4 (C-Term) Polyclonal Antibody | Cayman-10250-1 |
13,14-dihydro-15-keto Prostaglandin A2 | Cayman-10260-1 |
13,14-dihydro-15-keto Prostaglandin A2 | Cayman-10260-10 |
13,14-dihydro-15-keto Prostaglandin A2 | Cayman-10260-5 |
13,14-dihydro-15-keto Prostaglandin A2 | Cayman-10260-50 |
15-deoxy-Δ12,14-Prostaglandin A2 | Cayman-10265-0.5 |
15-deoxy-Δ12,14-Prostaglandin A2 | Cayman-10265-1 |
15-deoxy-Δ12,14-Prostaglandin A2 | Cayman-10265-10 |
15-deoxy-Δ12,14-Prostaglandin A2 | Cayman-10265-5 |
15(R)-15-methyl Prostaglandin A2 | Cayman-10270-1 |
15(R)-15-methyl Prostaglandin A2 | Cayman-10270-10 |
15(R)-15-methyl Prostaglandin A2 | Cayman-10270-100 |
15(R)-15-methyl Prostaglandin A2 | Cayman-10270-5 |
EUK 118 | Cayman-10271-10 |
EUK 118 | Cayman-10271-100 |
EUK 118 | Cayman-10271-5 |
EUK 118 | Cayman-10271-50 |
Prostratin | Cayman-10272-1 |
Prostratin | Cayman-10272-100 |
Prostratin | Cayman-10272-250 |
Prostratin | Cayman-10272-500 |
FABP3 Blocking Peptide | Cayman-10273-1 |
ATB-337 | Cayman-10277-1 |
ATB-337 | Cayman-10277-10 |
ATB-337 | Cayman-10277-5 |
ATB-337 | Cayman-10277-50 |
Soluble Epoxide Hydrolase (murine recombinant from E. coli) | Cayman-10278-100 |
Soluble Epoxide Hydrolase (murine recombinant from E. coli) | Cayman-10278-25 |
Soluble Epoxide Hydrolase (murine recombinant from E. coli) | Cayman-10278-50 |
PAF Acetylhydrolase (human recombinant) | Cayman-10279-100 |
PAF Acetylhydrolase (human recombinant) | Cayman-10279-25 |
PAF Acetylhydrolase (human recombinant) | Cayman-10279-50 |
16,16-dimethyl Prostaglandin A2 | Cayman-10280-1 |
16,16-dimethyl Prostaglandin A2 | Cayman-10280-10 |
16,16-dimethyl Prostaglandin A2 | Cayman-10280-5 |
16,16-dimethyl Prostaglandin A2 | Cayman-10280-50 |
16-phenoxy tetranor Prostaglandin A2 | Cayman-10285-1 |
16-phenoxy tetranor Prostaglandin A2 | Cayman-10285-10 |
16-phenoxy tetranor Prostaglandin A2 | Cayman-10285-100 |
16-phenoxy tetranor Prostaglandin A2 | Cayman-10285-5 |
17-phenyl trinor Prostaglandin A2 | Cayman-10288-1 |
17-phenyl trinor Prostaglandin A2 | Cayman-10288-10 |
17-phenyl trinor Prostaglandin A2 | Cayman-10288-5 |
17-phenyl trinor Prostaglandin A2 | Cayman-10288-50 |
17-phenyl trinor-13,14-dihydro Prostaglandin A2 | Cayman-10290-1 |
17-phenyl trinor-13,14-dihydro Prostaglandin A2 | Cayman-10290-10 |
17-phenyl trinor-13,14-dihydro Prostaglandin A2 | Cayman-10290-5 |
17-phenyl trinor-13,14-dihydro Prostaglandin A2 | Cayman-10290-50 |
19(R)-hydroxy Prostaglandin A2 | Cayman-10295-0.05 |
19(R)-hydroxy Prostaglandin A2 | Cayman-10295-0.1 |
19(R)-hydroxy Prostaglandin A2 | Cayman-10295-0.5 |
19(R)-hydroxy Prostaglandin A2 | Cayman-10295-5 |
NAPE-PLD (159-172) Blocking Peptide | Cayman-10303-1 |
NAPE-PLD Blocking Peptide (aa 6-20) | Cayman-10304-1 |
NAPE-PLD (159-172) Polyclonal Antibody | Cayman-10305-1 |
NAPE-PLD (6-20) Polyclonal Antibody | Cayman-10306-1 |
Prostaglandin A3 | Cayman-10310-0.1 |
Prostaglandin A3 | Cayman-10310-0.5 |
Prostaglandin A3 | Cayman-10310-1 |
Prostaglandin A3 | Cayman-10310-5 |
8,12-iso-iPF2α-VI 1,5- lactone | Cayman-10312-1 |
8,12-iso-iPF2α-VI 1,5- lactone | Cayman-10312-100 |
8,12-iso-iPF2α-VI 1,5- lactone | Cayman-10312-25 |
8,12-iso-iPF2α-VI 1,5- lactone | Cayman-10312-50 |
SIRT6 (human recombinant) | Cayman-10315-100 |
SIRT6 (human recombinant) | Cayman-10315-25 |
SIRT6 (human recombinant) | Cayman-10315-50 |
SIRT7 (human recombinant) | Cayman-10316-100 |
SIRT7 (human recombinant) | Cayman-10316-25 |
SIRT7 (human recombinant) | Cayman-10316-50 |
SIRT4 (human recombinant) | Cayman-10317-100 |
SIRT4 (human recombinant) | Cayman-10317-25 |
SIRT4 (human recombinant) | Cayman-10317-50 |
SIRT5 (human recombinant) | Cayman-10318-100 |
SIRT5 (human recombinant) | Cayman-10318-25 |
SIRT5 (human recombinant) | Cayman-10318-50 |
SET8 (human recombinant) | Cayman-10319-100 |
SET8 (human recombinant) | Cayman-10319-25 |
SET8 (human recombinant) | Cayman-10319-50 |
SET7/9 (human recombinant) | Cayman-10320-100 |
SET7/9 (human recombinant) | Cayman-10320-25 |
SET7/9 (human recombinant) | Cayman-10320-50 |
AFFINIMIP® GSH Selective Extraction Cartridges | Cayman-10323-10 |
AFFINIMIP® Tamoxifen Selective Extraction Catridges | Cayman-10324-10 |
Chemokine-Like Receptor 1 Polyclonal Antibody | Cayman-10325-1 |
Cystathionine γ-Lyase (human recombinant) | Cayman-10329-100 |
Cystathionine γ-Lyase (human recombinant) | Cayman-10329-25 |
Cystathionine γ-Lyase (human recombinant) | Cayman-10329-50 |
AdPLA2 Polyclonal Antibody | Cayman-10337-1 |
AdPLA2 Blocking Peptide | Cayman-10338-1 |
Griffithsin | Cayman-10340-100 |
Griffithsin | Cayman-10340-25 |
Griffithsin | Cayman-10340-50 |
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),環(huán)保在線對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。